GLP-1 medications may affect more than appetite and weight loss. Many patients report psychological changes such as reduced cravings, altered reward responses, shifts in mood, and changes in emotional eating behaviors. In this article, we explore the potential mental health benefits and risks of GLP-1 medications, helping patients better understand how these treatments may influence both the body and the mind.

A new weight loss pill is here. FOUNDAYO (orforglipron) offers a simpler, needle-free alternative to traditional GLP-1 injections like Semaglutide and Tirzepatide. Find out how it works, how much weight you can expect to lose, and whether this new option is right for you.

Clinical evidence for ibogaine in addiction treatment—primarily from observational studies outside the U.S.—suggests improvements in withdrawal, cravings, and mental health. However, the data is limited by lack of controlled trials, inconsistent protocols, and reliance on self-reported outcomes, raising important questions about reliability, safety, and long-term effectiveness.

Ibogaine treatment is a non-conventional intervention involving a psychoactive compound from the Tabernanthe iboga plant, producing a 24–72 hour intense physiological and psychological experience. Patients often report profound introspection and emotional insight, but the process carries significant risks, including cardiovascular and psychological concerns. Understanding the full patient experience is essential when evaluating both its therapeutic potential and safety.

Ibogaine is gaining attention as a potential treatment for addiction, particularly opioid dependence, often described as a “reset” for the brain. However, despite growing interest, it remains poorly understood, unapproved in the United States, and primarily used in international settings. Understanding its history, pharmacology, and current applications is essential to evaluating its role in modern addiction treatment.

GLP-1 weight loss treatments like semaglutide and tirzepatide are in high demand—but not all clinics are transparent about pricing. Some bundle medication into service fees, while others mark up drugs behind the scenes. Before starting treatment, it’s critical to understand how these programs are structured so you know exactly what you’re paying for—and what to watch out for.

The endocannabinoid system (ECS) is a regulatory network that helps maintain balance in the body. Through CB1 and CB2 receptors, it influences mood, pain, inflammation, metabolism, sleep, and immune function. When ECS signaling is disrupted, it may contribute to chronic conditions like migraine, IBS, fibromyalgia, and mood disorders. Supporting overall balance through lifestyle and targeted care may help restore healthy ECS function.

If you rely on a drink to wind down at night, it may be the reason you’re waking up exhausted. Learn why alcohol is a poor sleep aid and how it interferes with deep, restorative sleep.

Light cigarettes didn’t make smoking safer—they made the industry more profitable. Learn how misleading labels and engineered filters shaped one of tobacco’s most damaging myths.

This article explores how berberine may support weight loss by improving metabolic health, blood sugar regulation, and insulin sensitivity as part of a physician-guided approach.